Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T Naismith

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Neurology|October 24, 2019
Measuring disability in multiple sclerosis: Walking plus much moreMaria Pia Sormani, R T Naismith
Journal of Internal Medicine|January 22, 2014
Established and novel disease-modifying treatments in multiple sclerosisA H Cross, R T Naismith
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2007
Phenotype and prognosis in African-Americans with multiple sclerosis: a retrospective chart reviewR T Naismith, K Trinkaus, A H Cross
Neurology|May 26, 2010
Radial diffusivity in remote optic neuritis discriminates visual outcomesR T Naismith, J Xu, N T Tutlam, et al.
Biochimica Et Biophysica Acta|September 5, 1996
trans-2-phenylcyclopropylamine is a substrate for and inactivator of horseradish peroxidaseL M Sayre, R T Naismith, M A Bada, et al.
Neurology|July 1, 2009
Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritisR T Naismith, N T Tutlam, J Xu, et al.
Neurology|March 25, 2009
Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosisR T Naismith, N T Tutlam, J Xu, et al.
Neurology|March 25, 2009
NMO-IgG detected in CSF in seronegative neuromyelitis opticaE C Klawiter, E Alvarez, J Xu, et al.
Neurology|May 26, 2010
Increased diffusivity in acute multiple sclerosis lesions predicts risk of black holeR T Naismith, J Xu, N T Tutlam, et al.
Neurology|June 10, 2010
Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: a 52-week phase II trialR T Naismith, L Piccio, J A Lyons, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Neurology|October 24, 2019
Measuring disability in multiple sclerosis: Walking plus much moreMaria Pia Sormani, R T Naismith
Journal of Internal Medicine|January 22, 2014
Established and novel disease-modifying treatments in multiple sclerosisA H Cross, R T Naismith
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2007
Phenotype and prognosis in African-Americans with multiple sclerosis: a retrospective chart reviewR T Naismith, K Trinkaus, A H Cross
Neurology|May 26, 2010
Radial diffusivity in remote optic neuritis discriminates visual outcomesR T Naismith, J Xu, N T Tutlam, et al.
Biochimica Et Biophysica Acta|September 5, 1996
trans-2-phenylcyclopropylamine is a substrate for and inactivator of horseradish peroxidaseL M Sayre, R T Naismith, M A Bada, et al.
Neurology|July 1, 2009
Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritisR T Naismith, N T Tutlam, J Xu, et al.
Neurology|March 25, 2009
Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosisR T Naismith, N T Tutlam, J Xu, et al.
Neurology|March 25, 2009
NMO-IgG detected in CSF in seronegative neuromyelitis opticaE C Klawiter, E Alvarez, J Xu, et al.
Neurology|May 26, 2010
Increased diffusivity in acute multiple sclerosis lesions predicts risk of black holeR T Naismith, J Xu, N T Tutlam, et al.
Neurology|June 10, 2010
Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: a 52-week phase II trialR T Naismith, L Piccio, J A Lyons, et al.
Pageof 2